Neoadjuvant Treatment with Camrelizumab in Combination with Doxorubicin and Ifosfamide: A Phase II Clinical Study of High-Risk Soft Tissue Sarcoma.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)